COVID-19 Related Coagulopathy
novel coronavirus of zoonotic origin named “severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)” emerged at the end of 2019, in Wuhan province of China. The infection called COVID-19 was declared by World Health Organization a global pandemic. Coronavirüs disease-2019 (COVID-19) is frequent...
Main Author: | Seval AKPINAR |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayincilik
2020-12-01
|
Series: | Namık Kemal Tıp Dergisi |
Subjects: | |
Online Access: |
http://namikkemalmedj.com/archives/archive-detail/article-preview/covd-19-related-coagulopathy/43278
|
Similar Items
-
A Review of the Prevalence of Thromboembolic Complications among Pregnant Women Infected with COVID-19
by: Nurul Syafiqah Mohd Ariff, et al.
Published: (2022-10-01) -
Pregnancy associated coagulopathies in selected community hospitals in Southwest Nigeria
by: Bamisaye E Oluwaseyi, et al.
Published: (2021-01-01) -
Proposal of the Definition for COVID-19-Associated Coagulopathy
by: Toshiaki Iba, et al.
Published: (2021-01-01) -
Non-Overt Coagulopathy in Non-ICU Patients with Mild to Moderate COVID-19 Pneumonia
by: Daniela Mazzaccaro, et al.
Published: (2020-06-01) -
COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU
by: Runhui Zheng, et al.
Published: (2021-02-01)